Jaume Amat Presents Rob Surgical Systems at LSI Europe '23

Transcription

Jaume Amat  0:03  
Good afternoon, everyone. I'm Jaume Amat. I'm the CEO ofRob Surgical Systems, and I'm part of the founder team. So I'm really happy to share with you this amazing project that as you will see, we are playing in a really hot market. But we have a really specific value proposition to try to take part in this in this race. So as you probably as you as you know, 20 years after the physilogical robotic surgical procedure, the real use of robotics is still quite limited. So it's interesting to analyze that each of it perform its robot perform less than one surgery per day. And the market share of the robotics is below 5%. So if we analyze the laparoscopic surgery, device and equipment that we can find in the in the market, it's really interesting, because there are really different approaches, the conventional laparoscopic instruments the really simple, flexible and versatile, but the surgeon is working with just five degrees of freedom and using the manual precision and the other side of the picture identifies the large wave of the big players in the robotic market with a really specific approach and each one have this some advantage and disadvantage, and really specific differentiations. Between laparoscopic approach and robotic approach. There are a large series of instruments and equipments that they try to improve a little bit the advantage of the conventional laparoscopic approach and that between laparoscopic approach and robotic approach so when we analyze this, this market is when we detect real market needs. And we try to design a specific robotic platform to overcome the current limitations of the of these type of robotic solutions aren't going to talk about Beitrag system there is our specific bot, robot and platform that is designed with a really specific value proposition. So Beitrag system is the fierce for arms on demand open robotic platform, this is a quite complicated claim. So I'm going to repeat is the first for arms on demand open robotic platform. And I'm going to explain a little bit what it means. So the first part is, of course, we design a robotic platform, we have the robot the console, we are working with forearms. Of course, if you are using the robotic precision, we have seven degrees of freedom submillimeter precision. We design also a large list of endoscopy instruments. In our case, we design a single use instruments that is more useful for the hospitals because they don't need to carry out with the the logistical costs of the cleaning and restoration process. So this is the platform and this is what is looking for the main stakeholder of the sector. This is the passion, of course the passions are looking for safety and performance. And this is what we offer. But there are other stakeholders interested in this in the sector, and they have specific needs, the surgeon they are looking for accessibility, so is when we provide our specific approach we call hybrid approach or On Demand approach. And the idea is that the precision provided by the robot is not necessarily during all the surgical procedure. So we provide a system where the surgeon could use the robot just when is needed. So the idea that the surgeon could start the surgical procedure using manual instruments, or when the procedure is necessary in the really specific step of the surgery is when they could introduce the robotic instruments and take advantage of the procedure provided by the robot. So this is possible this really fast switch between lab and and meals. It's possible because we design a specific robotic platform really useful really versatile. The docking process is really easy. That location of the trocars in the domain is the same location of the surgeon we are using in the laparoscopic manual or Periscope. So the the process to move from Mr. Merz. It's simple, easy and really intuitive. So this is the characteristic that I said that open or the on demand or hybrid approach. Take into account the needs of the other stakeholder the hospital, the open platform is really interesting for them. Because we design an open platform where our system could be used in combination with a large list of endoscopy instruments and equipments. So it means that it's not necessary to have a dedicated otoscope tower isn't necessary to have a dedicated electro surgical unit. Because our system could we use it in combination with all of them. And this is really interesting because we could reduce the cost of the equipment that the hospitals have, because we improve the usability of this equipment. And the other really important advantage of this approach of the approach of the authoring platform is because, as you know, the balancing technology is changing all the time. So we have our system we could incorporate any new advantage of our new solution. For example, All in laparoscopic towers or individual visualization systems because we are agnostics, in in laparoscopic agnostics and laparoscopic towers. So we got to introduce any new advantage just when the market they will open new technology. So this is the the three main characteristics that we have or that the robot is the our robotic platform with forearms on demand of the hybrid approach and the concept of the open platform. Of course, this design habit tested during our preclinical studies, we had the opportunity to complete more than 100 surgical procedures in animal models, you think that, the pic model and then the collaborator model. So and we're having working close to close with the surgeon of different hospitals and different specializations. So we have a really good feedback of during our preclinical developments. In parallel, we are working with the surgeons, the new artificial intelligence tools to support them in some really specific steps of the surgery to try to improve a little bit, the precision and the precision and the safety of the system. Okay, so we've had the opportunity to test our advantage in the during the clinical studies, we receive a really good feedback from the surgeon and all the staff involved in the surgery. So it was the first time that they use or assist system and all the flow process. All the process during the surgical procedure works really, really differently. So it was fantastic experience working with them. Okay, just to summarize, as I said, hybrid approach, open platform, there are 30 of the platform and the cost reduction, because we are using the the equipment that the hospitals have in the opera conventional operating rooms, because we can combine all the older laparoscope towers, and as I said, Okay, so with this approach, and if we, as you as you know that the current systems are located in the top hospitals, doing the high complexity, surgery, high complex surgical procedures, with our approach, we could maintain this segment of this the same part of the market. But do you want to expand the use at the universalization of our system, because obviously, same could be useful to expand the number of surgeries isn't necessary to use the rubber just for really complex surgeries. And we're going to expand the number of hospitals that they are going to take advantage of our system. Okay. So as you can imagine, the market is really, really large. And there are several possibilities and potentials here. So I'm really happy because we have a really full committed team involved in the project, we have a really deep background that comes from the medtech industry and the r&d departments that support us in our r&d goals. Okay, this is the their fake the real picture that we have now, we are really close to reach the CE mark during the next year, and we have a really, we feel really comfortable with our regulatory strategy, because we had the opportunity to have a pre submission meeting with the FDA, and we receive the feedback of the FDA according or clinical development stage. So we know that all the developments that we are doing will be useful for the FDA approval. So this is the future goals that will have planet for the next two years. So as I said, we want to reach the same marking and second half of 2024. And the goal is that at the end of 2025 have the first 50 units installed and completed 500 surgeries. So as you can see, this is a really challenging project with a really specific value proposition. And of course, we will be happy if you want to join in our project. Take part of this really challenging project that's going to change the paradigm of robotic surgery. So thank you very much